NewGenIvf Group Ltd
NIVF1.000USD
0.0000.00%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
143.51KMarket Cap
0.00P/E TTM
More Details of NewGenIvf Group Ltd Company
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
NewGenIvf Group Ltd Info
Ticker SymbolNIVF
Company nameNewGenIvf Group Ltd
IPO dateFeb 15, 2022
CEOWing Fung (Siu)
Number of employees76
Security typeOrdinary Share
Fiscal year-endFeb 15
Address13/F, Ps Tower, Sukhumvit 21 Rd (Asoke)
CityBANGKOK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryThailand
Postal code- -
Phone
Websitehttps://newgenivf.com/
Ticker SymbolNIVF
IPO dateFeb 15, 2022
CEOWing Fung (Siu)
Company Executives of NewGenIvf Group Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Siu (Alfred) Wing Fung
Mr. Siu (Alfred) Wing Fung
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Fong (Tina) Hei Yue
Ms. Fong (Tina) Hei Yue
Chief Marketing Officer, Director
Chief Marketing Officer, Director
--
--
Mr. Au (Jefferson) Hok Man
Mr. Au (Jefferson) Hok Man
Independent Director
Independent Director
--
--
Ms. Wan Chan Ann Chi
Ms. Wan Chan Ann Chi
Independent Director
Independent Director
--
--
Mr. Wa Tam Chun
Mr. Wa Tam Chun
Independent Director
Independent Director
--
--
Mr. Fai Chung Ho
Mr. Fai Chung Ho
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Siu (Alfred) Wing Fung
Mr. Siu (Alfred) Wing Fung
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Fong (Tina) Hei Yue
Ms. Fong (Tina) Hei Yue
Chief Marketing Officer, Director
Chief Marketing Officer, Director
--
--
Mr. Au (Jefferson) Hok Man
Mr. Au (Jefferson) Hok Man
Independent Director
Independent Director
--
--
Ms. Wan Chan Ann Chi
Ms. Wan Chan Ann Chi
Independent Director
Independent Director
--
--
Mr. Wa Tam Chun
Mr. Wa Tam Chun
Independent Director
Independent Director
--
--
Mr. Fai Chung Ho
Mr. Fai Chung Ho
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2024Q4
FY2024Q3
FY2023
By BusinessUSD
Name
Revenue
Proportion
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
Kyrgyzstan
2.66M
48.89%
Thailand
2.18M
40.04%
Cambodia
601.53K
11.07%
HK SAR
0.00
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
Shareholding Stats
Updated: Mon, Feb 2
Updated: Mon, Feb 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.13%
JAK Opportunities VI LLC
0.10%
Other
99.77%
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.13%
JAK Opportunities VI LLC
0.10%
Other
99.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
0.14%
Corporation
0.10%
Individual Investor
0.03%
Other
99.73%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
34
1.53K
0.16%
+1.18K
2025Q3
39
5.79K
0.20%
+1.91K
2025Q2
46
23.90K
1.31%
+20.74K
2025Q1
47
53.83K
2.05%
+29.38K
2024Q4
57
480.38K
3.57%
+160.77K
2024Q3
54
388.28K
4.20%
+63.85K
2024Q2
55
392.14K
4.96%
+40.32K
2024Q1
48
150.75K
80.91%
-221.01K
2023Q4
49
198.33K
101.36%
-231.83K
2023Q3
47
276.28K
99.62%
-143.70K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
JAK Opportunities VI LLC
2.92K
0.22%
+2.92K
--
Apr 20, 2025
ATW Spac Management LLC
225.00
0.02%
+225.00
--
Oct 04, 2024
White Lion Capital LLC
140.00
0.01%
+140.00
--
Nov 21, 2024
SBI Securities Co., Ltd.
62.00
0%
+62.00
--
Sep 30, 2025
BofA Global Research (US)
2.00
0%
+2.00
--
Sep 30, 2025
RiverNorth Capital Management LLC
--
0%
-18.00
-100.00%
Sep 30, 2024
MMCAP Asset Management
--
0%
-10.00
-100.00%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jan 20, 2026
Merger
3→1
Nov 11, 2025
Merger
5→1
Jul 28, 2025
Merger
5→1
Apr 16, 2025
Merger
10→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Date
Ex-dividend Date
Type
Ratio
Jan 20, 2026
Merger
3→1
Nov 11, 2025
Merger
5→1
Jul 28, 2025
Merger
5→1
Apr 16, 2025
Merger
10→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
